Originally published by our sister publication Gastroenterology & Endoscopy News
Miguel Regueiro, MD
Professor of Medicine
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland
In this month’s The Regueiro Report, I’d like to highlight two exciting FDA approvals for moderately to severely active ulcerative colitis. Both approvals occurred this past October after two successful randomized, double-blind,